These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8100702)

  • 1. Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
    Capell HA; Porter DR; Madhok R; Hunter JA
    Ann Rheum Dis; 1993 Jun; 52(6):423-8. PubMed ID: 8100702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
    Situnayake RD; Grindulis KA; McConkey B
    Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
    van Jaarsveld CH; Jacobs JW; van der Veen MJ; Blaauw AA; Kruize AA; Hofman DM; Brus HL; van Albada-Kuipers GA; Heurkens AH; ter Borg EJ; Haanen HC; van Booma-Frankfort C; Schenk Y; Bijlsma JW
    Ann Rheum Dis; 2000 Jun; 59(6):468-77. PubMed ID: 10834865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.
    Felson DT; Anderson JJ; Meenan RF
    Arthritis Rheum; 1990 Oct; 33(10):1449-61. PubMed ID: 1977391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
    Crilly A; Madhok R; Watson J; Capell HA
    Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of second line therapy in rheumatoid arthritis.
    Porter DR; McInnes I; Hunter J; Capell HA
    Ann Rheum Dis; 1994 Dec; 53(12):812-5. PubMed ID: 7864689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of auranofin in patients with active early rheumatoid arthritis.
    Itokazu M; Matsunaga T; Oshita Y
    Clin Ther; 1995; 17(1):60-73. PubMed ID: 7758062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 20. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS; Greenwood M; Bird HA
    Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.